Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Exelixis Inc. Common Stock (EXEL) vs Grab Holdings Ltd. (GRAB) Price & Performance

Exelixis Inc. Common StockTrade
Grab Holdings Ltd.Trade

Price performance (Past 24H)

Key statistics

Exelixis Inc. Common Stock vs Grab Holdings Ltd. — how do they compare? Exelixis Inc. Common Stock trades at $60.35 (market cap $14.62B), while Grab Holdings Ltd. trades at $3.2 (market cap $12.72B). The key difference: Exelixis Inc. Common Stock and Grab Holdings Ltd. are close in size by market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Grab Holdings Ltd. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Grab Holdings Ltd. for 94 Days on average.

EXELGRAB
Market Cap
$14.62B$12.72B
Volume
2,684,95765,352,859
Sector
HealthTechnology
52-Week High
$59.13$6.17
52-Week Low
$34.54$2.80
Typical Hold Time
1 Days94 Days
Enterprise Value
$13.95B$8.46B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Exelixis Inc. Common Stock

No Aura AI signal available yet.

Grab Holdings Ltd.

Grab Holdings (GRAB) trades at $3.195, up 3.73% today, showing strong momentum after recent volatility. The stock demonstrates improving fundamentals with revenue growing from $2.8B in 2024 to $3.37B in 2025 and achieving profitability with $268M net income. Recent Q2 2026 earnings beat expectations with $0.06 EPS versus $0.05 expected, while technical indicators show bearish signals despite neutral oscillators. The company's $1.49B acquisition of Atome Financial positions it for financial services expansion.

Grab presents a compelling turnaround story with accelerating revenue growth and recent profitability. The strong analyst consensus (91.67% buy ratings) and $30M CEO share purchase signal confidence, though technical weakness and competitive pressures in Southeast Asia's ride-hailing market warrant caution. Key catalysts include continued execution on profitability targets and successful integration of Atome acquisition.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXEL

No sentiment data available yet.

GRAB
24% Buy76% Sell
Avg holding period · 94 Days

Top news

Latest headlines on both assets

About Exelixis Inc. Common Stock

Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.

Read more on EXEL →

About Grab Holdings Ltd.

Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.

Read more on GRAB →